An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
PHASE4CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
October 31, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
September 30, 2014
Conditions
Primary Open Angle GlaucomaOcular Hypertension
Interventions
DRUG
Saflutan® 15 microgram/ml Augentropfen im Einzeldosisbehältnis
Trial Locations (1)
1080
Ordination Dr. Hommer, Vienna
All Listed Sponsors
lead
Dr. Anton Hommer
OTHER
NCT01979913 - An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More | Biotech Hunter | Biotech Hunter